China Pediatric Devices and Diagnostics Expected To More Funding and Growth

Reimbursement Change Calls for Quality IVD
February 16, 2018
Concentrated Care in China Facilitates Clinical Trial Recruitment and Data Gathering
March 19, 2018

China Pediatric Devices and Diagnostics Expected To More Funding and Growth

In the National People’s Congress (NPC) and the Chinese People’s Political Consultative Conference (CPPCC) that are being held, representatives and committee members have all suggested that R & D for pediatric drugs and medical devices should be vigorously supported.

Due to second-child policy adopted in late 2016, the number of children in China will reach 260 million by 2020, providing greater opportunities for the market for children’s medical devices.

For the research and development of pediatric drugs, medical equipment and diagnostics, NPC deputies and CPPCC members proposed the inclusion of children’s medical services in major national science and technology projects. Accelerating children’s innovative research and development of medical devices, standardizing the management of children’s medical services, and simultaneously enabling children to benefit from the latest research results, is also a hot topic of current healthcare reform in China.